Subject of the day
OXB.L
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems; InAAVate, a proprietary plug and play' dual-plasmid system for transient transfection, as well as a standard triple transfection system for AAV-based gene therapies. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.
$487.50
▼ -5.00 (-1.0%)
| 52w hi | $913.00 |
|---|---|
| 52w lo | $478.50 |
| Vol | 324.04K |
| As of | Aug 13 |
Our score -0.43
| Short | -0.48 |
|---|---|
| Medium | -0.35 |
| Long | -0.46 |
computed 2026-08-13
Oxford Biomedica plc
Healthcare · Biotechnology
| Market cap | $590.09M |
|---|---|
| Enterprise value | $645.93M |
| Trailing P/E | — |
| Forward P/E | 75.78x |
| EV / EBITDA | -35.37x |
| P / S (ttm) | 3.50x |
| Profit margin | -17.9% |
| Return on equity | -40.4% |
| Revenue growth | +22.5% |
| Earnings growth | — |
| Debt / equity | 162.16 |
| Beta vs SPX | 0.02 |
|---|---|
| Corr SPX | 0.01 |
| Annual vol | 47.2% |
| Annual ret | +31.5% |
| Sharpe | 0.67 |
| Max DD | -48.4% |
Window: 504 trading days (491 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | -0.02 | |
| Sector | +0.12 | |
| Technical | -0.29 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $480.00 | $500.00 | $480.00 | $487.50 | 324.04K |
| Aug 12 | $500.00 | $500.00 | $481.00 | $492.50 | 890.39K |
| Aug 11 | $475.00 | $496.00 | $475.00 | $487.00 | 1.56M |
| Aug 10 | $503.00 | $505.00 | $478.50 | $478.50 | 1.99M |
| Aug 7 | $460.00 | $506.00 | $441.50 | $505.00 | 6.61M |